CSL Toekomstige groei

Future criteriumcontroles 3/6

CSL zal naar verwachting groeien in winst en omzet met respectievelijk 13% en 6.5% per jaar. De winst per aandeel zal naar verwachting groeien met 13% per jaar. Het rendement op het eigen vermogen zal over 3 jaar naar verwachting 18.5% zijn.

Belangrijke informatie

13.0%

Groei van de winst

13.0%

Groei van de winst per aandeel

Biotechs winstgroei15.5%
Inkomstengroei6.5%
Toekomstig rendement op eigen vermogen18.5%
Dekking van analisten

Good

Laatst bijgewerkt25 Nov 2024

Recente toekomstige groei-updates

CSL Limited (ASX:CSL) Just Reported Yearly Earnings: Have Analysts Changed Their Mind On The Stock?

Aug 16
CSL Limited (ASX:CSL) Just Reported Yearly Earnings: Have Analysts Changed Their Mind On The Stock?

Recent updates

With EPS Growth And More, CSL (ASX:CSL) Makes An Interesting Case

Nov 01
With EPS Growth And More, CSL (ASX:CSL) Makes An Interesting Case

We Think CSL (ASX:CSL) Can Stay On Top Of Its Debt

Oct 05
We Think CSL (ASX:CSL) Can Stay On Top Of Its Debt

CSL (ASX:CSL) Gains Approval for Updated COVID-19 Vaccine in Japan, Boosting Strategic Alliances

Sep 18
CSL (ASX:CSL) Gains Approval for Updated COVID-19 Vaccine in Japan, Boosting Strategic Alliances

Getting In Cheap On CSL Limited (ASX:CSL) Is Unlikely

Sep 03
Getting In Cheap On CSL Limited (ASX:CSL) Is Unlikely

CSL Limited (ASX:CSL) Just Reported Yearly Earnings: Have Analysts Changed Their Mind On The Stock?

Aug 16
CSL Limited (ASX:CSL) Just Reported Yearly Earnings: Have Analysts Changed Their Mind On The Stock?

An Intrinsic Calculation For CSL Limited (ASX:CSL) Suggests It's 27% Undervalued

Aug 07
An Intrinsic Calculation For CSL Limited (ASX:CSL) Suggests It's 27% Undervalued

CSL Limited's (ASX:CSL) Price Is Out Of Tune With Earnings

May 22
CSL Limited's (ASX:CSL) Price Is Out Of Tune With Earnings

An Intrinsic Calculation For CSL Limited (ASX:CSL) Suggests It's 20% Undervalued

May 01
An Intrinsic Calculation For CSL Limited (ASX:CSL) Suggests It's 20% Undervalued

Does CSL (ASX:CSL) Have A Healthy Balance Sheet?

Mar 19
Does CSL (ASX:CSL) Have A Healthy Balance Sheet?

CSL Limited's (ASX:CSL) Earnings Haven't Escaped The Attention Of Investors

Feb 02
CSL Limited's (ASX:CSL) Earnings Haven't Escaped The Attention Of Investors

Is CSL (ASX:CSL) Using Too Much Debt?

Dec 10
Is CSL (ASX:CSL) Using Too Much Debt?

CSL Limited (ASX:CSL) Shares Could Be 28% Below Their Intrinsic Value Estimate

Nov 16
CSL Limited (ASX:CSL) Shares Could Be 28% Below Their Intrinsic Value Estimate

These 4 Measures Indicate That CSL (ASX:CSL) Is Using Debt Reasonably Well

Sep 11
These 4 Measures Indicate That CSL (ASX:CSL) Is Using Debt Reasonably Well

CSL Limited's (ASX:CSL) Intrinsic Value Is Potentially 47% Above Its Share Price

Aug 13
CSL Limited's (ASX:CSL) Intrinsic Value Is Potentially 47% Above Its Share Price

CSL (ASX:CSL) Has A Pretty Healthy Balance Sheet

May 30
CSL (ASX:CSL) Has A Pretty Healthy Balance Sheet

A Look At The Intrinsic Value Of CSL Limited (ASX:CSL)

May 09
A Look At The Intrinsic Value Of CSL Limited (ASX:CSL)

Does CSL (ASX:CSL) Have A Healthy Balance Sheet?

Mar 01
Does CSL (ASX:CSL) Have A Healthy Balance Sheet?

Estimating The Fair Value Of CSL Limited (ASX:CSL)

Feb 07
Estimating The Fair Value Of CSL Limited (ASX:CSL)

CSL (ASX:CSL) Seems To Use Debt Quite Sensibly

Nov 17
CSL (ASX:CSL) Seems To Use Debt Quite Sensibly

CSL Limited (ASX:CSL) Shares Could Be 24% Below Their Intrinsic Value Estimate

Oct 27
CSL Limited (ASX:CSL) Shares Could Be 24% Below Their Intrinsic Value Estimate

We Think CSL (ASX:CSL) Can Stay On Top Of Its Debt

Aug 19
We Think CSL (ASX:CSL) Can Stay On Top Of Its Debt

Is CSL Limited (ASX:CSL) Trading At A 22% Discount?

Jul 29
Is CSL Limited (ASX:CSL) Trading At A 22% Discount?

CSL's (ASX:CSL) Problems Go Beyond Weak Profit

Feb 22
CSL's (ASX:CSL) Problems Go Beyond Weak Profit

Winst- en omzetgroeiprognoses

ASX:CSL - Toekomstschattingen van analisten en financiële gegevens uit het verleden (USD Millions )
DatumInkomstenInkomstenVrije kasstroomGeldmiddelen uit operationele activiteitenGem. Aantal analisten
6/30/202718,0344,1314,1134,96614
6/30/202616,8993,6273,5884,36915
6/30/202515,7703,0962,9663,79215
6/30/202414,8002,6421,5062,764N/A
3/31/202414,4902,5571,3322,727N/A
12/31/202314,1792,4721,1582,690N/A
9/30/202313,7452,3331,0342,646N/A
6/30/202313,3102,1949092,601N/A
3/31/202312,5072,1567652,392N/A
12/31/202211,7052,1186222,182N/A
9/30/202211,1332,1861,0012,406N/A
6/30/202210,5622,2551,3812,629N/A
3/31/202210,5872,2901,2512,679N/A
12/31/202110,6122,3251,1212,728N/A
9/30/202110,4612,3501,5383,175N/A
6/30/202110,3102,3751,9553,622N/A
3/31/202110,1452,5202,1273,597N/A
12/31/20209,9802,6652,2993,571N/A
9/30/20209,5652,3841,7103,030N/A
6/30/20209,1512,1031,1212,488N/A
3/31/20209,0482,0541,0092,418N/A
12/31/20198,9442,0068972,347N/A
9/30/20198,7421,9626281,996N/A
6/30/20198,5391,9193601,644N/A
3/31/20198,4061,8614261,621N/A
12/31/20188,2741,8034921,597N/A
9/30/20188,0941,7667011,750N/A
6/30/20187,9151,7299101,902N/A
3/31/20187,6661,674N/A1,662N/A
12/31/20177,4171,618N/A1,422N/A
9/30/20177,1821,478N/A1,335N/A
6/30/20176,9471,337N/A1,247N/A
3/31/20176,8021,333N/A1,192N/A
12/31/20166,6561,329N/A1,138N/A
9/30/20166,3861,286N/A1,158N/A
6/30/20166,1151,242N/A1,179N/A
3/31/20165,9831,324N/A1,296N/A
12/31/20155,8501,406N/A1,413N/A
9/30/20155,6541,392N/A1,388N/A
6/30/20155,4591,379N/A1,364N/A
3/31/20155,4821,366N/A1,434N/A
12/31/20145,5051,354N/A1,504N/A
9/30/20145,4201,330N/A1,432N/A
6/30/20145,3351,307N/A1,361N/A
3/31/20145,1891,270N/A1,257N/A
12/31/20135,0421,233N/A1,154N/A

Toekomstige groeivoorspellingen analisten

Verdiensten versus spaarpercentage: De verwachte winstgroei CSL ( 13% per jaar) ligt boven de spaarquote ( 2.6% ).

Winst versus markt: De winst van CSL ( 13% per jaar) zal naar verwachting sneller groeien dan de Australian markt ( 12.6% per jaar).

Hoge groeiwinsten: De winst van CSL zal naar verwachting groeien, maar niet aanzienlijk.

Omzet versus markt: De omzet van CSL ( 6.5% per jaar) zal naar verwachting sneller groeien dan de markt Australian ( 5.8% per jaar).

Hoge groei-inkomsten: De omzet van CSL ( 6.5% per jaar) zal naar verwachting langzamer groeien dan 20% per jaar.


Groeiprognoses winst per aandeel


Toekomstig rendement op eigen vermogen

Toekomstige ROE: Het rendement op eigen vermogen CSL zal naar verwachting over 3 jaar laag zijn ( 18.5 %).


Ontdek groeibedrijven